Back | Next |
home / stock / sprb / sprb message board
Subject | By | Source | When |
---|---|---|---|
The gaining | pzottkpz | investorshub | 04/16/2023 7:03:24 PM |
oh yeah news for the day | MiamiGent | investorshub | 04/16/2023 6:22:52 AM |
Time for a bounce? | TheFinalCD | investorshub | 04/16/2023 5:05:38 AM |
$SPRB Looks pretty positive | pzottkpz | investorshub | 04/15/2023 12:10:16 PM |
now that | pzottkpz | investorshub | 02/09/2023 8:05:58 PM |
bahahahaha | pzottkpz | investorshub | 02/09/2023 2:32:06 PM |
took this one | pzottkpz | investorshub | 01/26/2023 5:10:29 PM |
its like a circus act | pzottkpz | investorshub | 01/19/2023 4:03:02 PM |
does the | pzottkpz | investorshub | 01/19/2023 10:44:36 AM |
mama said | pzottkpz | investorshub | 01/18/2023 9:57:48 PM |
cant wait to see | pzottkpz | investorshub | 01/18/2023 1:10:32 PM |
pumpy dumpy | pzottkpz | investorshub | 01/17/2023 6:36:58 PM |
this stock only seems to have | pzottkpz | investorshub | 01/17/2023 6:09:24 PM |
lying pumpers | pzottkpz | investorshub | 01/15/2023 1:45:30 PM |
$SPRB drop was bot. | MiamiGent | investorshub | 01/13/2023 6:38:12 PM |
does anyone know | pzottkpz | investorshub | 01/12/2023 9:09:26 PM |
someone | pzottkpz | investorshub | 01/12/2023 2:41:05 PM |
reminder | pzottkpz | investorshub | 01/12/2023 4:50:10 AM |
$SPRB Closed at 2.90 + .29 or + 11.11% | MiamiGent | investorshub | 01/12/2023 12:51:13 AM |
stock | pzottkpz | investorshub | 01/11/2023 5:16:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Spruce Biosciences Inc. Company Name:
SPRB Stock Symbol:
NASDAQ Market:
Spruce Biosciences Inc. Website:
Spruce Biosciences, Inc . (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant unmet medical need, announced that the San Francisco Business Times and the Silicon Valley Busines...
Pairs Spruce’s Investigational Product Candidate, Tildacerfont, with HMNC’s Companion Diagnostic, the Proprietary Cortibon Genetic Selection Tool, to Treat MDD Patients Responsive to CRF 1 Receptor Antagonism Provides Spruce with Option to In-License Exclusive Worldwide ...
Significant Reduction in Dehydroepiandrosterone Sulfate ( DHEAS) Versus Placebo Observed in Women with Elevated DHEAS Levels at Baseline Increase in Serum Sex Hormone Binding Globulin (SHBG) Versus Placebo Observed Tildacerfont was Well-Tolerated with No Safety Signals ...